CLL Cello Health Plc

TIDMCLL

RNS Number : 2214M

Cello Health PLC

26 April 2018

26 April 2018

Cello Health plc

("Cello" or the "Company")

Change of Name

Further to the announcement made on 25 April 2018, the Company confirms that its change of name to "Cello Health plc" is now effective, and that the Company's ticker symbol "CLL" remains unchanged.

Cello Health plc shares continue to be traded on the AIM market of the London Stock Exchange. Shareholdings are unaffected by the name change, and existing share certificates should be retained, as they will remain valid for all purposes. Any new share certificates issued after 25 April 2018 will bear the name Cello Health plc.

The Company's website address has now also changed to www.cellohealthplc.com.

Enquiries:

Cello Health plc

    Mark Scott, Chief Executive                        020 7812 8460 

Mark Bentley, Group Finance Director

Cenkos Securities plc

    Mark Connelly                                                   020 7397 8900 

Harry Hargreaves

Buchanan

Mark Court

    Jamie Hooper                                                    020 7466 5000 

Sophie Wills

This information is provided by RNS

The company news service from the London Stock Exchange

END

CANIFMPTMBJTMLP

(END) Dow Jones Newswires

April 26, 2018 04:45 ET (08:45 GMT)

Cello Health (LSE:CLL)
Historical Stock Chart
From Apr 2024 to May 2024

Cello Health (LSE:CLL)
Historical Stock Chart
From May 2023 to May 2024